| The role of HER2 in cancer therapy and targeted drug delivery W Tai, R Mahato, K Cheng Journal of controlled release 146 (3), 264-275, 2010 | 676 | 2010 |
| Prodrugs for improving tumor targetability and efficiency R Mahato, W Tai, K Cheng Advanced drug delivery reviews 63 (8), 659-670, 2011 | 408 | 2011 |
| Nanoemulsion as targeted drug delivery system for cancer therapeutics R Mahato Journal of pharmaceutical sciences and pharmacology 3 (2), 83-97, 2017 | 78 | 2017 |
| Blocking IKKα expression inhibits prostate cancer invasiveness R Mahato, B Qin, K Cheng Pharmaceutical research 28, 1357-1369, 2011 | 46 | 2011 |
| Development of streptavidin-based nanocomplex for siRNA delivery RS Shukla, W Tai, R Mahato, W Jin, K Cheng Molecular pharmaceutics 10 (12), 4534-4545, 2013 | 30 | 2013 |
| Multifunctional micro-and nanoparticles R Mahato Emerging nanotechnologies for diagnostics, drug delivery and medical devices …, 2017 | 27 | 2017 |
| Microneedles in drug delivery R Mahato Emerging nanotechnologies for diagnostics, drug delivery and medical devices …, 2017 | 21 | 2017 |
| Emerging Nanotechnologies for Diagnostics R Mahato Drug Delivery and Medical Devices. Elsevier, 331-353, 2017 | 8 | 2017 |
| Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices R Mahato | 4 | 2017 |
| Evaluation of siRNA mediated silencing of IKKα in prostate cancer and CD40 in type-1 diabetes R Mahato University of Missouri-Kansas City, 2014 | | 2014 |
| DELIVERY OF VACCINES HR DESU, R MAHATO, LA THOMA Advanced Drug Delivery, 275, 2013 | | 2013 |
Wanyi TaiSchool of Pharmaceutical Sciences,Wuhan University,China在 whu.edu.cn 的电子邮件经过验证
